# IBANDRONATE SODIUM
> **ANDA202235** · Abbreviated New Drug Application (Generic) · Sponsor: CHEMI SPA · Approved 2014-09-02
## Drug
- **FDA Application Number:** ANDA202235
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IBANDRONATE SODIUM
- **Generic name:** Ibandronate Sodium
- **Active ingredients:** IBANDRONATE SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** CHEMI SPA
- **First approval:** 2014-09-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202235)
---
*MORVS · CC0 1.0*